Mylan 1Q Revenues: $1.6 billion (+3%)   1Q Earnings: $107.5 million (-17%)   Comments: Third party revenues from Mylan’s Generics segment were $1.4 billion, up 2%. North America revenues were $732.8 million, up 5%. EMEA revenues were $369.9 million, up 10%. Asia Pacific revenues were $305.1 million, up 2%. Mylan’s Specialty segment sales were $211.6 million, up 24% driven by EPIPEN Auto-Injector. Earnings include expenses related to R&D licensing payments of $23 million and acqu...